Emotional drivers are an under-researched and increasingly important dynamic to understand in today's competitive pharmaceutical landscape. However, many pharmaceutical manufacturers struggle to assess the emotional landscape surrounding their markets and products, particularly from a quantitative perspective.
Common questions we hear from our clients include: How can I quantify the role of emotion in influencing prescribing and satisfaction in my therapeutic area? How big of a role does emotion play in comparison to clinical factors? How can I increase the positive associations that physicians have toward my product?
Psyma and RONIN Corporation teamed together in Spring 2009 to conduct a study with 300 physicians - half primary care physicians and half specialists - to answer these questions. Results from this study were originally presented as a University Session at PBIRG's 49th annual AGM in May 2009. This 30-minute session highlights key findings and implications from this research.
To view this webinar, please click here.